Global Diagnostic Specialty Antibodies Market (2020 to 2027) - by Type, Application, End-user and Region -

·3 min read

DUBLIN, July 26, 2021--(BUSINESS WIRE)--The "Global Diagnostic Specialty Antibodies Market 2020-2027 by Type, Application, End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity" report has been added to's offering.

Global diagnostic specialty antibodies market will reach $28.97 billion by 2027, growing by 4.9% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for specialty diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer.

Highlighted with 79 tables and 70 figures, this report is based on a comprehensive research of the entire global diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year.

Key Players:

  • Abbott Laboratories

  • Abcam plc

  • Agilent Technologies, Inc.

  • Aytu BioScience, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • Boehringer Ingelheim International GmbH

  • Creative Diagnostics

  • Enzo Life Sciences, Inc.

  • F. Hoffmann-La Roche AG

  • Merck KGaA

  • Polymun Scientific Immunbiologische Forschung GmbH

  • Sanofi S.A.

  • Sartorius AG

  • Thermo Fisher Scientific Inc.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure

  • Growth Drivers

  • Restraints and Challenges

  • Emerging Product Trends & Market Opportunities

  • Porter's Five Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Region.

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Five Forces Analysis

3 Segmentation of Global Market by Type

3.1 Market Overview by Type

3.2 Monoclonal Antibodies

3.3 Polyclonal Antibodies

3.4 Other Types

4 Segmentation of Global Market by Application

4.1 Market Overview by Application

4.2 Oncology Diagnosis

4.3 Hepatitis Diagnosis

4.4 Infectious Disease Diagnosis

4.5 Dengue Diagnostics

4.6 Tuberculosis Diagnostics

4.7 HIV Diagnostics

4.8 Other Applications

5 Segmentation of Global Market by End User

5.1 Market Overview by End User

5.2 Hospitals & Clinics

5.3 Diagnostic Laboratories

5.4 Other End Users

6 Segmentation of Global Market by Region

7 Competitive Landscape

7.1 Overview of Key Vendors

7.2 New Product Launch, Partnership, Investment, and M&A

7.3 Company Profiles

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting